NYSE - Nasdaq Real Time Price USD

Thermo Fisher Scientific Inc. (TMO)

572.38 +1.13 (+0.20%)
At close: May 3 at 4:00 PM EDT
572.36 -0.02 (-0.00%)
After hours: May 3 at 7:50 PM EDT
Loading Chart for TMO
DELL
  • Previous Close 571.25
  • Open 579.84
  • Bid 540.00 x 800
  • Ask 580.00 x 800
  • Day's Range 571.63 - 579.84
  • 52 Week Range 415.60 - 603.82
  • Volume 1,749,670
  • Avg. Volume 1,339,563
  • Market Cap (intraday) 218.487B
  • Beta (5Y Monthly) 0.80
  • PE Ratio (TTM) 36.76
  • EPS (TTM) 15.57
  • Earnings Date Jul 24, 2024 - Jul 29, 2024
  • Forward Dividend & Yield 1.56 (0.27%)
  • Ex-Dividend Date Mar 14, 2024
  • 1y Target Est 622.29

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

www.thermofisher.com

122,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TMO

Performance Overview: TMO

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TMO
7.91%
S&P 500
7.50%

1-Year Return

TMO
5.53%
S&P 500
24.47%

3-Year Return

TMO
22.57%
S&P 500
22.64%

5-Year Return

TMO
108.49%
S&P 500
75.76%

Compare To: TMO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TMO

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    218.49B

  • Enterprise Value

    246.84B

  • Trailing P/E

    36.71

  • Forward P/E

    26.53

  • PEG Ratio (5yr expected)

    2.31

  • Price/Sales (ttm)

    5.21

  • Price/Book (mrq)

    4.80

  • Enterprise Value/Revenue

    5.81

  • Enterprise Value/EBITDA

    21.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.20%

  • Return on Assets (ttm)

    4.82%

  • Return on Equity (ttm)

    13.62%

  • Revenue (ttm)

    42.49B

  • Net Income Avi to Common (ttm)

    6.03B

  • Diluted EPS (ttm)

    15.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.25B

  • Total Debt/Equity (mrq)

    78.05%

  • Levered Free Cash Flow (ttm)

    6.08B

Research Analysis: TMO

Company Insights: TMO

Research Reports: TMO

People Also Watch